These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35530959)

  • 41. Role of the Demethylase AlkB Homolog H5 in the Promotion of Dentinogenesis.
    Tian C; Chai J; Liu W; Zhang X; Li Y; Zuo H; Yuan G; Zhang H; Liu H; Chen Z
    Front Physiol; 2022; 13():923185. PubMed ID: 35784864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of ALKBH5-mediated m
    Guo Y; Song W; Yang Y
    Environ Toxicol; 2022 Apr; 37(4):910-924. PubMed ID: 34995009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ALKBH5 facilitates the progression of skin cutaneous melanoma via mediating ABCA1 demethylation and modulating autophagy in an m
    Wang H; Zhao S; Liu H; Liu Y; Zhang Z; Zhou Z; Wang P; Qi S; Xie J
    Int J Biol Sci; 2024; 20(5):1729-1743. PubMed ID: 38481816
    [No Abstract]   [Full Text] [Related]  

  • 44. m
    Wang B; Fang X; Sun X; Du C; Zhou L; Lv X; Li Y; Li H; Tang W
    Life Sci; 2021 Aug; 278():119577. PubMed ID: 33961858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1.
    Sun W; Li Y; Ma D; Liu Y; Xu Q; Cheng D; Li G; Ni C
    Cell Mol Biol Lett; 2022 Mar; 27(1):26. PubMed ID: 35279083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulated FTO Promotes MicroRNA-155-mediated Inflammatory Response in Cerebral Ischemia/Reperfusion Injury.
    Jiang Z; Shi L; Huang H; Lei D; Lou L; Jin Y; Sun J; Wang L
    Neuroscience; 2023 Aug; 526():305-313. PubMed ID: 37437797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
    Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
    Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of ALKBH5 inhibits inflammation and excessive proliferation by promoting TRIM13 m6A modifications in glomerular mesangial cells.
    Hu X; Liu T; Zhuang X; Wei L; Gao J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6779-6789. PubMed ID: 38536435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
    Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
    Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N6-methyladenosine RNA demethylase ALKBH5 is testis-specifically downregulated in hybrid male sterile dzo and is a target gene of bta-miR-200a.
    Chen H; Zhang J; Yan Y; Zhu C; Wang L; Fu S; Zuo F; Zhang GW
    Theriogenology; 2022 Jul; 187():51-57. PubMed ID: 35504087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ALKBH5-Mediated RNA m
    Kuang Y; Li R; Wang J; Xu S; Qiu Q; Lin S; Liu D; Shen C; Liu Y; Xu M; Lin W; Zhang S; Liang L; Xu H; Xiao Y
    Arthritis Rheumatol; 2024 Feb; 76(2):192-205. PubMed ID: 37584615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.
    Chen J; Xu C; Yang K; Gao R; Cao Y; Liang L; Chen S; Xu S; Rong R; Wang J; Zhu T
    Nat Commun; 2023 Mar; 14(1):1161. PubMed ID: 36859428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N6-Methyladenosine Demethylase ALKBH5 Promotes Pyroptosis by Modulating PTBP1 mRNA Stability in LPS-Induced Myocardial Dysfunction.
    Liu M; Chen X
    Acta Cardiol Sin; 2024 May; 40(3):312-321. PubMed ID: 38779157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The N6-Methyladenosine Regulator
    Zhao Y; Sun J; Jin L
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
    Zhen L; Pan W
    Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ALKBH5-mediated m
    Huang X; Zhao Y; Liu D; Gu S; Liu Y; Khoong Y; Luo S; Zhang Z; Xia W; Wang M; Liang H; Li M; Li Q; Zan T
    Inflamm Regen; 2023 Jul; 43(1):36. PubMed ID: 37452367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ALKBH5-YTHDF2 m6A modification axis inhibits rheumatoid arthritis progression by suppressing NLRP3.
    Xiao J; Cai X; Wang R; Zhou W; Ye Z
    Biochem Biophys Res Commun; 2023 Aug; 668():70-76. PubMed ID: 37244037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of MAPK signaling pathway mediated by ITGB3 gene silencing on myocardial ischemia-reperfusion injury in mice and its mechanism.
    Wang MC; Wang D; Lu YH; Li ZH; Jing HY
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):820-836. PubMed ID: 33577037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9.
    Li Y; Yan B; Wang X; Li Q; Kan X; Wang J; Sun Y; Wang P; Tian L; Liu M
    J Cell Mol Med; 2022 Jan; 26(2):385-398. PubMed ID: 34850551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.